RaiaDrogasil
RADL3.SA
#2160
Rank
โ‚ฌ7.68 B
Marketcap
4,31ย โ‚ฌ
Share price
5.99%
Change (1 day)
28.30%
Change (1 year)

P/E ratio for RaiaDrogasil (RADL3.SA)

P/E ratio as of February 2026 (TTM): 35.0

According to RaiaDrogasil's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 35.0431. At the end of 2024 the company had a P/E ratio of 30.5.

P/E ratio history for RaiaDrogasil from 2010 to 2025

PE ratio at the end of each year

Year P/E ratio Change
202430.5-31.98%
202344.920.99%
202237.1-28.42%
202151.8-36.88%
202082.180.02%
201945.629.13%
201835.3-36.64%
201755.832.51%
201642.132.35%
201531.8-7.3%
201434.3-21.15%
201343.5-34.29%
201266.225.2%
201152.9123.2%
201023.727.36%
200918.691.58%
20089.71-69.03%
200731.4240.75%
20069.20175.14%
20053.34-30.44%
20044.819.46%
20034.39

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.